pristiq logo
Important Safety Information Medication Guide for Patients Prescribing Information Health Care Professionals
    • What is PRISTIQ?
    • Common Questions
    • Getting Results
    • Common Side Effects
    • How to Take PRISTIQ
    • How Your Doctor Can Help
    • Create a Doctor
        Discussion Guide
    • Track Your Progress
    • Get Savings & Support
    • Activate Savings Card

Get Adobe Flash player
save pristiq
Create a Doctor
Discussion Guide
save pristiq
Save on PRISTIQ

Important Safety Information About PRISTIQ

Suicidality and Antidepressant Drugs

Antidepressants increased the risk of suicidal thinking and behavior in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy or when the dose is changed should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior such as becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Should these occur, report them to a doctor right away. PRISTIQ is not approved for use in children under 18.

Do not take PRISTIQ if you are allergic to desvenlafaxine, venlafaxine, or any of the ingredients in PRISTIQ. Do not take PRISTIQ if you currently take, or have taken within the last 14 days, any medicine known as an MAOI (including intravenous methylene blue or the antibiotic linezolid). Allow 7 days after stopping PRISTIQ before starting an MAOI. Taking an MAOI with PRISTIQ can cause serious or even life-threatening side effects.

Before taking PRISTIQ, tell your healthcare professional about all prescription and over-the-counter medications and supplements you take or plan to take including: those to treat migraines or psychiatric disorders (including other antidepressants) to avoid serotonin syndrome, a potentially life-threatening condition; aspirin, NSAID pain relievers, or blood thinners because they may increase the risk of bleeding.

PRISTIQ may cause or worsen some conditions, so tell your healthcare professional about all the medical conditions you have or had including:

  • High blood pressure, which should be controlled before starting PRISTIQ and monitored regularly
  • Heart problems, high cholesterol or triglyceride levels, a history of stroke, glaucoma or increased eye pressure, kidney or liver problems, or low sodium levels in your blood
  • Bleeding problems
  • Depression, suicidal thoughts or behavior
  • Mania, bipolar disorder, or seizures or convulsions
  • Nursing, pregnancy, or plans to become pregnant

Discontinuation symptoms may occur when stopping or reducing PRISTIQ, so talk to your healthcare professional before stopping or changing your dose.

Until you see how PRISTIQ affects you, be careful driving a car or operating machinery. Avoid drinking alcohol while taking PRISTIQ.

In clinical studies, most common side effects with PRISTIQ 50 mg were nausea, dizziness, sweating, constipation, and decreased appetite.

INDICATION

PRISTIQ® (desvenlafaxine) is a prescription medication approved for the treatment of major depressive disorder in adults.

Please see full Prescribing Information, including boxed warning, and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

 
Important Safety Information    |     Medication Guide for Patients    |     Prescribing Information    |
Health Care Professionals    |    Press Releases    |    Unsubscribe    |    Pfizer.com    |
Contact Us    |     Privacy Policy    |     Privacy Policy FAQs    |     Terms of Use    |    Site Map
 
Copyright © 2013 Pfizer Inc. All rights reserved. PQP533710-01 PQP533612-01